Mikkel Jürgens

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma

Paul J. Bröckelmann, Horst Müller, Olivier Casasnovas et al. · Annals of Oncology · 2017 · 93 citations · Full text

Medicine, Hematology, Oncology +16

Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial

Mikkel Jürgens, Morten Schou, Philip Hasbak et al. · Journal of the American Heart Association · 2021 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial

Mads Ersbøll, Mikkel Jürgens, Philip Hasbak et al. · International journal of cardiac imaging · 2021 · 22 citations

Medicine, Cardiology, Pharmacology +16

Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial

Emil Wolsk, Mikkel Jürgens, Morten Schou et al. · Diabetes · 2022 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the <scp>SIMPLE</scp> randomized clinical trial

Niels Brandt, Mikkel Jürgens, Philip Hasbak et al. · Diabetes Obesity and Metabolism · 2022 · 11 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17